Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 1867 > 

1867-66-9

Products Categories

Basic Information
CAS No.: 1867-66-9
Name: Ketamine hydrochloride
Article Data: 4
Molecular Structure:
Molecular Structure of 1867-66-9 (Ketamine hydrochloride)
Formula: C13H16ClNO.ClH
Molecular Weight: 274.19
Synonyms: DEA No. 7285;Ketaset;(+-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride;
EINECS: 217-484-6
Density: 1.17g/cm3
Melting Point: 252-254°C
Boiling Point: 363.8°C at 760 mmHg
Flash Point: 173.8°C
Solubility: H2O: 200 mg/mL
Appearance: white
Hazard Symbols: HarmfulXn
Risk Codes: 22-36/37/38
Safety: 26
Transport Information: 3249
PSA: 29.10000
LogP: 4.09070
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Specification

 The Ketamine hydrochloride, with the CAS registry number 1867-66-9,is also known as (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride. It belongs to the product categories of Intermediates & Fine Chemicals;Pharmaceuticals. This chemical's molecular formula is C13H16ClNO.HCl and molecular weight is 274.19. What's more,Its systematic name is Ketamine hydrochloride. It is a off-white solid which is a cyclohexanone derivative used for induction of anesthesia. its mechanism of action is not well understood, but ketamine can block nmda receptors (receptors, n-methyl-d-aspartate) and may interact with sigma receptors. Ketamine hydrochloride is harmful if swallowed and irritating to eyes, respiratory system and skin .In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

Physical properties about Ketamine hydrochloride are:
(1)ACD/LogP:  3.012; (2)# of Rule of 5 Violations:  0; (3)ACD/LogD (pH 5.5):  2.01; (4)ACD/LogD (pH 7.4):  2.97; (5)ACD/BCF (pH 5.5):  11.46; (6)ACD/BCF (pH 7.4):  102.86; (7)ACD/KOC (pH 5.5):  103.64; (8)ACD/KOC (pH 7.4):  930.33; (9)#H bond acceptors:  2; (10)#H bond donors:  1; (11)#Freely Rotating Bonds:  2; (12)Index of Refraction:  1.562; (13)Molar Refractivity:  65.724 cm3; (14)Molar Volume:  202.594 cm3; (15)Polarizability:  26.055 10-24cm3 ; (16)Surface Tension:  43.8880004882813 dyne/cm; (17)Density:  1.173 g/cm3; (18)Flash Point:  173.816 °C; (19)Enthalpy of Vaporization:  60.99 kJ/mol; (20)Boiling Point:  363.792 °C at 760 mmHg; (21)Vapour Pressure:  0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:CNC1(CCCCC1=O)c2ccccc2Cl;
(2)Std. InChI:InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3;
(3)Std. InChIKey:YQEZLKZALYSWHR-UHFFFAOYSA-N.

The toxicity data of Ketamine hydrochloride are as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
chicken LD50 intravenous 67900ug/kg (67.9mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: TREMOR

BEHAVIORAL: SLEEP
American Journal of Veterinary Research. Vol. 45, Pg. 531, 1984.
child TDLo intramuscular 4mg/kg (4mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Annals of Emergency Medicine. Vol. 22, Pg. 613, 1993.
child TDLo intramuscular 4mg/kg (4mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
American Journal of Emergency Medicine. Vol. 14, Pg. 580, 1996.
child TDLo intravenous 13200ug/kg (13.2mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Annals of Emergency Medicine. Vol. 34, Pg. 492, 1999.
guinea pig LD50 intramuscular 361mg/kg (361mg/kg)   Veterinary and Human Toxicology. Vol. 24, Pg. 410, 1982.
human TDLo intravenous 2mg/kg (2mg/kg) BEHAVIORAL: ANALGESIA British Medical Journal. Vol. 2, Pg. 943, 1976.
infant TDLo multiple routes 11587ug/kg (11.587mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA British Journal of Anesthesia. Vol. 58, Pg. 573, 1986.
man LDLo oral 13333ug/kg (13.333mg/kg) LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA Journal of Forensic Sciences. Vol. 39, Pg. 1314, 1994.
man TDLo unreported 1mg/kg (1mg/kg) BEHAVIORAL: ANALGESIA

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: COMA
U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#03551,
mouse LD50 intramuscular 356mg/kg (356mg/kg)   Zhongguo Yaolixue Yu Dulixue Zazhi. Vol. 9, Pg. 96, 1995.
mouse LD50 intraperitoneal 224mg/kg (224mg/kg)   Drugs in Japan Vol. 6, Pg. 264, 1982.
mouse LD50 intravenous 55900ug/kg (55.9mg/kg)   Drugs in Japan Vol. 6, Pg. 264, 1982.
mouse LD50 oral 617mg/kg (617mg/kg)   Drugs in Japan Vol. 6, Pg. 264, 1982.
rat LD50 intraperitoneal 224mg/kg (224mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat LD50 intravenous 58880ug/kg (58.88mg/kg)   Drugs in Japan Vol. 6, Pg. 264, 1982.
rat LD50 oral 447mg/kg (447mg/kg)   Drugs in Japan Vol. 6, Pg. 264, 1982.
rat LDLo intraspinal 5mg/kg (5mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE Acta Pharmacologica et Toxicologica. Vol. 56, Pg. 50, 1985.